Research Article A systems pharmacology approach for targeted study of potential inflammatory pathways and their genes in atherosclerosis Sanaa Almowallad 1, Raja Jeet 2 and Mohammad Mobashir 3,* 1 Department of Biochemistry, Faculty of Sciences, University of Tabuk, Tabuk, 71491, Saudi Arabia; salmowaled@ut.edu.sa (S.A.). 2 G D College, Begusarai, 851101, Bihar, India; rajajeet10@gmail.com (R.J.). 3 […]
7 February 2025 in Global Journal of Basic Science
Colorectal cancer is a type of cancer that begins in the colon or rectum, and it is also known as colon cancer or rectal cancer, depending on where it begins. Colorectal cancer is one of the most common and deadly cancers, with a wide range of outcomes and medication responses. The human papillomavirus produces benign and malignant neoplasms in epidermal and mucosal epithelial cells. HPVs that are often found in anogenital malignancies, particularly cancers of the cervix and anus, are classified as high-risk or oncogenic. The PARK2 gene is one of the most important genes known to be linked to the ubiquitin proteasomal system and to play a role in cancer and other serious disorders. In order to comprehend the genotype-phenotype relationship in complicated disorders, high-throughput data (genomic and proteomic) is commonly collected. In this study, we focused on the relationship between the human papillomavirus, the PARK2 gene, gene expression patterns, altered genes, and their activities in colorectal cancer. We got the data from a publically available database for gene expression, mutations, and structural variants in human colorectal cancer for this study. We looked at it in terms of clinical importance by combining the Gene Expression Omnibus, TCGA, and ProteinAtlas datasets. According to our findings, the PARK2 gene impacts not only the ubiquitin proteasomal systems, but also key pathways, particularly those involved with the immune system, which may be directly responsible for colorectal and other types of cancer, as well as other key human disorders. Furthermore, it demonstrates that the HPV-infected genes and their estimated roles were potentially shared with genes that are important components of well-known colorectal cancer control and coordination pathways.
15 February 2025 in Global Journal of Basic Science
One of the most important problems in biomedicine is still drug development. AI-assisted drug development has emerged as a new trend, especially in anticipating drug-target relationships, as a result of the big data era and the quick growth of information technologies like artificial intelligence (AI). By efficiently extracting information from intricate biological data, properly modeling molecular interactions, and reliably forecasting possible drug-target outcomes, AI-driven models have become viable tools to tackle the problem of drug-target prediction. Convolutional neural networks (CNNs), graph convolutional networks (GCNs), transformers, and other sophisticated deep learning designs, as well as traditional machine learning (ML) and network-based approaches, are essential. Drug-target interaction prediction is a challenging task. AI-based DTI prediction can greatly increase speed, lower costs, and screen possible drug design choices prior to real tests thanks to the emergence of artificial intelligence (AI) techniques like machine learning and deep learning. Nevertheless, there are a number of issues with the use of AI techniques that must be resolved. This article examines several AI-based strategies and makes recommendations for potential future developments.
31 December 2024 in Global Journal of Basic Science
Editorial Phytomedicine as the alternative drug against the human disease Raja Jeet 1 1 Department of Botany, G D College, Begusarai, 851101, Bihar, India. * Correspondence: rajajeet10@gmail.com (R.J.) Citation: Jeet R. Phytomedicine as the alternative drug against human disease. Jour. Bas. Sci. 2024, 7(1). 1-3. Received: September 09, 2024 Revised: October 22, 2024 Accepted: […]
7 November 2024 in Global Journal of Basic Science
Review Systems-level understanding of toxicology and cardiovascular system Sana Almowallad 1,*, Raja Jeet 2 and Mohammad Mobashir 3,* 1 Department of Biochemistry, Faculty of Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia; salmowaled@ut.edu.sa. 2 Department of Botany, G D College, Begusarai, 851101, Bihar, India; rajajeet10@gmail.com. 3 Department of Biomedical Laboratory Science, Norwegian University of Science […]
29 August 2024 in Journal of Plant Biochemistry and Biotechnology